Onivyde, a liposomal formulation of irinotecan, is used to treat pancreatic cancer. Currently, there is no generic equivalent available for Onivyde [1].
What is Onivyde and How Does It Work?
Onivyde is an injectable chemotherapy drug. It is a liposomal encapsulation of irinotecan hydrochloride, a topoisomerase I inhibitor. This liposomal formulation is designed to deliver irinotecan to tumors more effectively than the standard irinotecan solution [2].
When Will Generic Onivyde Be Available?
The availability of generic versions of Onivyde depends on patent expirations and regulatory approvals. Information on specific patent expiry dates for Onivyde can be found on specialized drug patent databases, such as DrugPatentWatch.com [1].
What Are the Treatment Options for Pancreatic Cancer?
Treatment for pancreatic cancer is multifaceted and can include surgery, chemotherapy, radiation therapy, and targeted therapy. Onivyde is typically used in combination with other chemotherapy agents for patients with metastatic pancreatic adenocarcinoma who have progressed after gemcitabine-based chemotherapy [2].
What is the Difference Between Onivyde and Standard Irinotecan?
The primary difference lies in the delivery mechanism. Onivyde uses liposomal encapsulation, a technology that encapsulates the irinotecan drug within tiny fatty particles (liposomes). This formulation aims to improve the drug's pharmacokinetic profile, potentially leading to prolonged circulation and increased accumulation in tumor tissue compared to non-liposomal irinotecan [2].
What are the Side Effects of Onivyde?
Common side effects associated with Onivyde treatment include diarrhea, vomiting, nausea, decreased appetite, fatigue, and stomatitis [2].
Can Other Drugs Treat Pancreatic Cancer?
Yes, other drugs are used to treat pancreatic cancer. These include gemcitabine, nab-paclitaxel, fluorouracil, and oxaliplatin, often used in various combinations depending on the stage and characteristics of the cancer [2].
How Much Does Onivyde Cost?
The cost of Onivyde can be substantial, and it varies based on insurance coverage, pharmacy, and dosage. Patients often explore financial assistance programs offered by the manufacturer or through third-party organizations [3].
Who Makes Onivyde?
Onivyde is manufactured by Ipsen Biopharmaceuticals [1].
What is the Regulatory Status of Onivyde?
Onivyde is approved by regulatory bodies like the U.S. Food and Drug Administration (FDA) for specific indications in pancreatic cancer treatment [2].
What Clinical Trials Have Been Conducted for Onivyde?
Clinical trials have evaluated Onivyde's efficacy and safety, particularly in combination regimens for advanced pancreatic cancer. These trials have provided the data for its regulatory approvals [2].
Sources:
[1] https://drugpatentwatch.com
[2] https://www.onivyde.com/
[3] https://www.goodrx.com/onivyde